Chemical Communications · 2017 · 41 citations · 25 references
PharmacyPharmaceutical BiotechnologyPharmaceuticsDrug DeliveryNanomaterialsNanoparticle Drug DeliveryCancer NanomedicineDrug EncapsulationNanomedicineNanoparticle Delivery SystemsNanoparticle DesignNanoparticle FormulationsCancer NanotherapyDrug Delivery NanocarriersDrug Release MechanismsMultifunctional NanoparticlesNanoparticle Drug DistributionNanoparticle Toxicity ReductionNanoparticle-based Controlled ReleaseNanoparticles
We here provide the first report on the construction of nanoparticles formulating highly potent cytotoxic therapeutics using albumin. Maytansinoid DM1 can be efficiently integrated into albumin nanoparticles, resulting in remarkable alleviation of in vivo drug toxicity and expanding the repertoire of albumin technology available for cancer therapy.
25
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma, David Miles, Luca Gianni et al. · New England Journal of Medicine · 2012 · 3.8K citations · Full text
Medicine, Oncology, Pharmacology +14
Structural Basis of the Drug-binding Specificity of Human Serum Albumin
J. Ghuman, Patricia A. Zunszain, I. Petitpas et al. · Journal of Molecular Biology · 2005 · 1.9K citations